Literature DB >> 24317067

Protease-deficient Saccharomyces cerevisiae strains for the synthesis of human-compatible glycoproteins.

Kazuya Tomimoto1, Yasuko Fujita, Tomoko Iwaki, Yasunori Chiba, Yoshifumi Jigami, Ken-ichi Nakayama, Yoshihiro Nakajima, Hiroko Abe.   

Abstract

Saccharomyces cerevisiae strains engineered previously to produce proteins with mammalian high mannose structures showed severe growth defects and decreased protein productivity. In strain YAB101, derived from one of these strains by a mutagenesis technique based on the disparity theory of evolution, these undesirable phenotypes were alleviated. Here we describe further engineering of YAB101 with the aim of synthesizing heterologous glycoproteins with Man5GlcNAc2, an intermediate for the mammalian hybrid and complex type oligosaccharides. About 60% conversion of Man8GlcNAc2 to Man5GlcNAc2 was observed after integration of Aspergillus saitoi α-1,2-mannosidase fused to the transmembrane domain of S. cerevisiae Och1. To obtain a higher yield of the target protein, a protease-deficient version of this strain was generated by disruption of PEP4 and PRB1, resulting in YAB101-4. Inactivation of these vacuolar proteases enhanced the secretion of human interferon-β by approximately 10-fold.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24317067     DOI: 10.1271/bbb.130588

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  5 in total

1.  RNAi expression tuning, microfluidic screening, and genome recombineering for improved protein production in Saccharomyces cerevisiae.

Authors:  Guokun Wang; Sara M Björk; Mingtao Huang; Quanli Liu; Kate Campbell; Jens Nielsen; Haakan N Joensson; Dina Petranovic
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-18       Impact factor: 11.205

Review 2.  Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up.

Authors:  Aravind Madhavan; K B Arun; Raveendran Sindhu; Jayaram Krishnamoorthy; R Reshmy; Ranjna Sirohi; Arivalagan Pugazhendi; Mukesh Kumar Awasthi; George Szakacs; Parameswaran Binod
Journal:  Microb Cell Fact       Date:  2021-06-30       Impact factor: 5.328

3.  Engineering O-glycosylation in modified N-linked oligosaccharide (Man12GlcNAc2∼Man16GlcNAc2) Pichia pastoris strains.

Authors:  Siqiang Li; Peng Sun; Xin Gong; Shaohong Chang; Enzhong Li; Yuanhong Xu; Jun Wu; Bo Liu
Journal:  RSC Adv       Date:  2019-03-12       Impact factor: 4.036

4.  Engineering a natural Saccharomyces cerevisiae strain for ethanol production from inulin by consolidated bioprocessing.

Authors:  Da Wang; Fu-Li Li; Shi-An Wang
Journal:  Biotechnol Biofuels       Date:  2016-04-30       Impact factor: 6.040

Review 5.  Edible Vaccines: Promises and Challenges.

Authors:  Vrinda M Kurup; Jaya Thomas
Journal:  Mol Biotechnol       Date:  2020-02       Impact factor: 2.695

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.